192 related articles for article (PubMed ID: 33420237)
1. Factors associated with left ventricular reverse remodelling after percutaneous coronary intervention in patients with left ventricular systolic dysfunction.
Adachi Y; Kiyosue A; Ando J; Kawahara T; Kodera S; Minatsuki S; Kikuchi H; Inaba T; Kiriyama H; Hirose K; Shinohara H; Saito A; Fujiwara T; Hara H; Ueda K; Sakakura K; Hatano M; Harada M; Takimoto E; Akazawa H; Morita H; Momomura SI; Fujita H; Komuro I
Sci Rep; 2021 Jan; 11(1):239. PubMed ID: 33420237
[TBL] [Abstract][Full Text] [Related]
2. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies.
Kunadian V; Pugh A; Zaman AG; Qiu W
Coron Artery Dis; 2012 Nov; 23(7):469-79. PubMed ID: 22960383
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes and reverse remodelling in recently diagnosed unexplained left ventricular systolic dysfunction.
Kuchynka P; Podzimkova J; Marek J; Danek BA; Vitkova I; Kreidlova M; Roblova L; Kovarnik T; Simek S; Horak J; Habasko J; Linhart A; Palecek T
ESC Heart Fail; 2024 Apr; 11(2):859-870. PubMed ID: 38204216
[TBL] [Abstract][Full Text] [Related]
5. Revascularization in Patients With Left Main Coronary Artery Disease and Left Ventricular Dysfunction.
Park S; Ahn JM; Kim TO; Park H; Kang DY; Lee PH; Jeong YJ; Hyun J; Lee J; Kim JH; Yang Y; Choe K; Park SJ; Park DW;
J Am Coll Cardiol; 2020 Sep; 76(12):1395-1406. PubMed ID: 32943156
[TBL] [Abstract][Full Text] [Related]
6. Improvement of left ventricular function after percutaneous coronary intervention in patients with stable coronary artery disease and preserved ejection fraction: Impact of diabetes mellitus.
Sikora-Frac M; Zaborska B; Maciejewski P; Budaj A; Bednarz B
Cardiol J; 2021; 28(6):923-931. PubMed ID: 31257568
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous coronary intervention in patients with stable coronary artery disease and left ventricular systolic dysfunction: insights from the VA CART program.
Brophy TJ; Warsavage TJ; Hebbe AL; Plomondon ME; Waldo SW; Rao SV; DeVore AD; Gutierrez JA; Swaminathan RV
Am Heart J; 2021 May; 235():149-157. PubMed ID: 33567318
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of left ventricular reverse remodeling after catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction.
Okada M; Tanaka N; Oka T; Tanaka K; Ninomiya Y; Hirao Y; Yoshimoto I; Inoue H; Kitagaki R; Onishi T; Koyama Y; Okamura A; Iwakura K; Sakata Y; Fujii K; Inoue K
J Cardiol; 2021 May; 77(5):500-508. PubMed ID: 33272779
[TBL] [Abstract][Full Text] [Related]
9. Recovery of Left Ventricular Function After Percutaneous Coronary Intervention Compared to Coronary Artery Bypass Grafting in Patients with Multi-Vessel Coronary Disease and Left Ventricular Dysfunction.
Yee NP; Siu AM; Davis J; Kao J
Hawaii J Med Public Health; 2016 Sep; 75(9):273-7. PubMed ID: 27688953
[TBL] [Abstract][Full Text] [Related]
10. High body mass index is a predictor of left ventricular reverse remodelling in heart failure with reduced ejection fraction.
Cescau A; Van Aelst LNL; Baudet M; Cohen Solal A; Logeart D
ESC Heart Fail; 2017 Nov; 4(4):686-689. PubMed ID: 28752617
[TBL] [Abstract][Full Text] [Related]
11. High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction.
Daubert MA; Massaro J; Liao L; Pershad A; Mulukutla S; Magnus Ohman E; Popma J; O'Neill WW; Douglas PS
Am Heart J; 2015 Sep; 170(3):550-8. PubMed ID: 26385039
[TBL] [Abstract][Full Text] [Related]
12. Clinical Determinants and Prognosis of Left Ventricular Reverse Remodelling in Non-Ischemic Dilated Cardiomyopathy.
Díez-López C; Salazar-Mendiguchía J; García-Romero E; Fuentes L; Lupón J; Bayés-Genis A; Manito N; de Antonio M; Moliner P; Zamora E; Catalá-Ruiz P; Caínzos-Achirica M; Comín-Colet J; González-Costello J
J Cardiovasc Dev Dis; 2022 Jan; 9(1):. PubMed ID: 35050230
[TBL] [Abstract][Full Text] [Related]
13. Physiological benefits evaluated by quantitative flow ratio in patients with reduced left ventricular ejection fraction who underwent percutaneous coronary intervention.
Zhong J; Chen Q; Chen L; Ye Z; Chen H; Sun J; Hong J; Ye M; Yan Y; Chen L; Luo Y
BMC Cardiovasc Disord; 2020 Dec; 20(1):523. PubMed ID: 33317462
[TBL] [Abstract][Full Text] [Related]
14. Meta-Analysis Comparing Percutaneous Coronary Revascularization Using Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients With Left Ventricular Systolic Dysfunction.
Cui K; Zhang D; Lyu S; Song X; Yuan F; Xu F; Zhang M
Am J Cardiol; 2018 Nov; 122(10):1670-1676. PubMed ID: 30220418
[TBL] [Abstract][Full Text] [Related]
15. Rotational Atherectomy for Severely Calcified Lesions in Patients With Left Ventricular Systolic Dysfunction: One-Year Outcomes From aSingle-Center Registry Analysis.
Yoshida R; Ishii H; Morishima I; Tanaka A; Takagi K; Yoshioka N; Morita Y; Unno K; Yoshida Y; Tsuboi H; Murohara T
Cardiovasc Revasc Med; 2020 Oct; 21(10):1220-1227. PubMed ID: 32457019
[TBL] [Abstract][Full Text] [Related]
16. Regression of left ventricular hypertrabeculation is associated with improvement in systolic function and favorable prognosis in adult patients with non-ischemic cardiomyopathy.
Minamisawa M; Koyama J; Kozuka A; Miura T; Ebisawa S; Motoki H; Okada A; Izawa A; Ikeda U
J Cardiol; 2016 Nov; 68(5):431-438. PubMed ID: 26740463
[TBL] [Abstract][Full Text] [Related]
17. Myocardial recovery after percutaneous coronary intervention in coronary artery disease patients with impaired systolic function- predictive utility of global longitudinal strain.
Khaled S; Shalaby G
Indian Heart J; 2022; 74(6):488-493. PubMed ID: 36372350
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular reverse remodelling predicts long-term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry.
Adamo M; Godino C; Giannini C; Scotti A; Liga R; Curello S; Fiorina C; Chiari E; Chizzola G; Abbenante A; Visco E; Branca L; Fiorelli F; Agricola E; Stella S; Lombardi C; Colombo A; Petronio AS; Metra M; Ettori F
Eur J Heart Fail; 2019 Feb; 21(2):196-204. PubMed ID: 30549159
[TBL] [Abstract][Full Text] [Related]
19. Determinants of Left Ventricular Systolic Function Improvement Following Coronary Artery Revascularization in Heart Failure Patients With Reduced Ejection Fraction (HFrEF).
Adachi Y; Sakakura K; Wada H; Funayama H; Umemoto T; Fujita H; Momomura S
Int Heart J; 2016 Sep; 57(5):565-72. PubMed ID: 27628418
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular reverse remodeling in dilated cardiomyopathy- maintained subclinical myocardial systolic and diastolic dysfunction.
Amorim S; Rodrigues J; Campelo M; Moura B; Martins E; Macedo F; Silva-Cardoso J; Maciel MJ
Int J Cardiovasc Imaging; 2017 May; 33(5):605-613. PubMed ID: 28013418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
